Stocks and Investing Stocks and Investing
Tue, November 8, 2016

Salim Syed Initiated (BIIB) at Hold and Held Target at $290 on, Nov 8th, 2016


Published on 2024-10-25 19:13:20 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $290 on, Nov 8th, 2016.

Salim has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Salim's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Maintained at Hold with Decreased Target to $316 on, Wednesday, October 5th, 2016


These are the ratings of the 3 analyists that currently disagree with Salim


  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy on, Monday, November 7th, 2016
  • Geoffrey Porges of "Leerink Swann" Upgraded from Hold to Buy on, Monday, November 7th, 2016
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $368 on, Wednesday, August 17th, 2016

Contributing Sources